Tapentadol Extended Release in the Treatment of Severe Chronic Low Back Pain and Osteoarthritis Pain

Pain Relief

Efficacy and safety of tapentadol prolonged-release for moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo- and oxycodone controlled-release studies

Curr Med Res Opin.

Lange B, von Zabern D, Elling C, Dubois C

doi: 10.1080/

Pain Relief

Tapentadol prolonged-release for moderate-to-severe chronic osteoarthritis knee pain: a double-blind, randomized, placebo- and oxycodone controlled release-controlled study

Curr Med Res Opin.

Serrie A, Lange B, Steup A

doi: 10.1080/

RECOMMENDED

Back Pain

Analgesic efficacy, safety, and tolerability of a long-acting abuse-deterrent formulation of oxycodone for moderate-to-severe chronic low back pain in subjects successfully switched from immediate-release oxycodone

doi: 10.2147/JPR.S168836.

Back PainChronic Pain

Is non-pharmacological treatment an effective option for chronic low back pain?

Ondrejkovicova A, Petrovics G, Svitkova K, Balogh V

Back PainChronic Pain

The relationship between catastrophizing and altered pain sensitivity in patients with chronic low-back pain

Pain.

Meints SM, Mawla I, Napadow V, Kong J, Gerber J, Chan ST, Wasan AD, Kaptchuk TJ, McDonnell C, Carriere J, Rosen B, Gollub RL, Edwards RR

doi: 10.1097/j.pain.0000000000001461.

COMMENTED

Back Pain

Efficacy of Low-Dose Amitriptyline for Chronic Low Back Pain

doi: 10.1001/jamainternmed.

Back PainChronic Pain

The Impact of Anxiety and Depression on the Outcomes of Chronic Low Back Pain Multidisciplinary Pain Management-A Multicenter Prospective Cohort Study in Pain Clinics with One-Year Follow-up

Pain Med.

Oliveira DS, Vélia Ferreira Mendonça L, Sofia Monteiro Sampaio R, Manuel Pereira Dias de Castro-Lopes J, Ribeiro de Azevedo LF

doi: 10.1093/pm/pny128.

Back PainChronic Pain

Variability in negative emotions among individuals with chronic low back pain: relationships with pain and function

Pain.

Gerhart JI, Burns JW, Bruehl S, Smith DA, Post KM, Porter LS, Schuster E, Buvanendran A, Fras AM, Keefe FJ

doi: 10.1097/

COMMENTED

Back Pain

The relationship between catastrophizing and altered pain sensitivity in patients with chronic low back pain

Pain.

Meints SM, Mawla I, Napadow V, Kong J, Gerber J, Chan ST, Wasan AD, Kaptchuk TJ, McDonnell C, Carriere J, Rosen B, Gollub RL, Edwards RR

doi: 10.1097/j.pain.

Related content

Efficacy and safety of tapentadol prolonged-release for moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo- and oxycodone controlled-release studies

Tapentadol prolonged-release for moderate-to-severe chronic osteoarthritis knee pain: a double-blind, randomized, placebo- and oxycodone controlled release-controlled study

Analgesic efficacy, safety, and tolerability of a long-acting abuse-deterrent formulation of oxycodone for moderate-to-severe chronic low back pain in subjects successfully switched from immediate-release oxycodone

Is non-pharmacological treatment an effective option for chronic low back pain?

The relationship between catastrophizing and altered pain sensitivity in patients with chronic low-back pain

Efficacy of Low-Dose Amitriptyline for Chronic Low Back Pain

The Impact of Anxiety and Depression on the Outcomes of Chronic Low Back Pain Multidisciplinary Pain Management-A Multicenter Prospective Cohort Study in Pain Clinics with One-Year Follow-up

Variability in negative emotions among individuals with chronic low back pain: relationships with pain and function

The relationship between catastrophizing and altered pain sensitivity in patients with chronic low back pain